The NRF2 is a key regulator of the cell’s adaptative response to radical oxidant species and xenobiotics through the interaction with its negative regulator, Keap1, and contributes to cancer development, progression, and chemoresistance [18,20,21]. Here, NFE2L2 is linked to cancer.